EN
News
-
MedGenCell's PD-1 Gene-Edited T Cell Injection Approved for Clinical TrialsAccording to the CDE official website, MedGencell (Beijing) Co., Ltd(hereinafter referred to as "MedGencell") has received approval for its Investigational New ···2024-02-01More
-
Milestone: World's First CRISPR Gene Editing Therapy Approved in the UK!On November 16, the world's first CRISPR gene editing therapy (Exa-cel, CASGEVY™) received conditional approval from the UK's Medicines and Healthcare products···2023-11-17More
-
First clinical trial application for gene-edited T-cell drug for solid tumors formally accepted by State Drug Administration (SDA)According to the open literature, its “PD-1 gene-edited T-cell injection” IIT phase I clinical trial has proved its scientific validity, feasibility and safet···2022-10-23More
-
Embracing the 20th National Congress: Talents United with the Party, Pursuing Dreams in the New EraOn the eve of the 20th National Congress of the Party, the Chengdu Rongdrifters Talent Comprehensive Party Committee and the Chengdu Talent Development Promotio···2022-10-17More
-
Voices of ”Rongpiao" Talents | Deng Tao: Science Has No Borders, But Scientists Have a MotherlandTo celebrate the 100th anniversary of the founding of the Communist Party of China, on June 26th, the Chengdu Talent Office hosted a themed event titled "Promot···2021-07-02More
-
The article co-authored by Dr. Deng Tao and the GCP Center of the Chinese Academy of Medical Sciences has been published in CANCER CELL, a sub-journal of Cell.On January 12, 2021, the article co-authored by Dr. Deng Tao and the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences/GCP (Good Clini···2021-02-18More
-
「EmedClub」Chengdu MedGenCeLl: Nature Medicine Reports Results of the World's First Complete Phase I Clinical Trial of a CRISPR-Edited T-Cell ArticleThe picture shows Dr. Deng Tao being interviewed exclusively by EmedclubQ1: Hello Dr. Deng, can you tell us a little bit about the background of this clinical t···2024-10-18More
-
Chengdu MedGenCell Co., Ltd was recognized as a “Sunrise Enterprise” by the “2019 China-Japan Advanced Medical and New Drug R&D Summit Forum and Achievement Transformation Conference”Chengdu MedGenCell Co., Ltd was invited to participate in the “2019 China-Japan Advanced Medical and New Drug R&D Summit Forum and Achievement Transformation C···2024-10-18More
